CME
Reconsidering the Algorithm: DME
Host: Christina Y. Weng, MD, MBA Host: Durga Borkar, MD, MMCi The approval of new, more durable treatments is an exciting development for the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME),